Close Menu

Writing in The Scientist, Steven Wiley examines the merits of renewing his annual society memberships. Wiley writes that every year it comes time to pay society dues, he asks himself "should I bother?" In the past, he says, membership benefits were often tangible ― they arrived in the mail in the form of print journals and invitations to submit abstracts for annual meetings ― whereas now, many society publications are freely accessible online.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.